[go: up one dir, main page]

HUP0100094A3 - Novel surface antigen - Google Patents

Novel surface antigen

Info

Publication number
HUP0100094A3
HUP0100094A3 HU0100094A HUP0100094A HUP0100094A3 HU P0100094 A3 HUP0100094 A3 HU P0100094A3 HU 0100094 A HU0100094 A HU 0100094A HU P0100094 A HUP0100094 A HU P0100094A HU P0100094 A3 HUP0100094 A3 HU P0100094A3
Authority
HU
Hungary
Prior art keywords
surface antigen
novel surface
novel
antigen
Prior art date
Application number
HU0100094A
Other languages
English (en)
Original Assignee
Univ Queensland Brisbane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10823587&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0100094(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Queensland Brisbane filed Critical Univ Queensland Brisbane
Publication of HUP0100094A1 publication Critical patent/HUP0100094A1/hu
Publication of HUP0100094A3 publication Critical patent/HUP0100094A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU0100094A 1997-12-12 1998-12-14 Novel surface antigen HUP0100094A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726398.2A GB9726398D0 (en) 1997-12-12 1997-12-12 Polypeptide and coding sequences
PCT/AU1998/001031 WO1999031132A1 (en) 1997-12-12 1998-12-14 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)

Publications (2)

Publication Number Publication Date
HUP0100094A1 HUP0100094A1 (hu) 2001-05-28
HUP0100094A3 true HUP0100094A3 (en) 2003-08-28

Family

ID=10823587

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100094A HUP0100094A3 (en) 1997-12-12 1998-12-14 Novel surface antigen

Country Status (17)

Country Link
US (8) US6197312B1 (hu)
EP (2) EP2354230A1 (hu)
JP (2) JP4356961B2 (hu)
KR (1) KR100571533B1 (hu)
CN (2) CN1284965A (hu)
AU (1) AU747742B2 (hu)
BR (1) BR9814276A (hu)
CA (1) CA2314319C (hu)
CZ (1) CZ299646B6 (hu)
GB (1) GB9726398D0 (hu)
HU (1) HUP0100094A3 (hu)
IL (2) IL136684A0 (hu)
NO (1) NO20002990L (hu)
NZ (1) NZ505374A (hu)
PL (1) PL205984B1 (hu)
TR (1) TR200001709T2 (hu)
WO (1) WO1999031132A1 (hu)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
PT1047784E (pt) * 1998-01-14 2009-12-21 Novartis Vaccines & Diagnostic Antigénios de neisseria meningitidis
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
EP2261348A3 (en) 1998-05-01 2012-01-25 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
AU2004240199B2 (en) * 1999-04-30 2007-05-17 Novartis Vaccines And Diagnostics S.R.L. Conserved Neisserial antigens
WO2000066741A2 (en) * 1999-04-30 2000-11-09 Chiron S.P.A. Conserved neisserial antigens
BR0010303A (pt) * 1999-05-04 2002-02-13 Monsanto Technology Llc Composições de polipeptìdeos tóxicas para os coleópteros e plantas transgênicas resistentes aos insetos
AU783894B2 (en) * 1999-05-19 2005-12-22 Novartis Vaccines And Diagnostics S.R.L. Combination neisserial compositions
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
JP2004508801A (ja) * 1999-10-29 2004-03-25 カイロン　ソチエタ　ア　レスポンサビリタ　リミタータ ナイセリア抗原性ペプチド
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
EP1741784B1 (en) 1999-11-29 2010-03-10 Novartis Vaccines and Diagnostics S.r.l. 85kDa neisserial antigen
US8273360B2 (en) 2000-01-17 2012-09-25 Novartis Ag Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
US7947291B2 (en) * 2000-01-25 2011-05-24 The University Of Queensland Modified surface antigen
AU2005202972B2 (en) * 2000-01-25 2008-04-24 The University Of Queensland Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
RU2299906C2 (ru) 2000-02-28 2007-05-27 Новартис Вэксинс Энд Диагностикс С.Р.Л. Гетерологичная экспрессия белков neisseria
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
EP1412381B1 (en) 2001-07-27 2010-06-02 Novartis Vaccines and Diagnostics S.r.l. Antibodies against meningococcal adhesin app
GB0129007D0 (en) * 2001-12-04 2002-01-23 Chiron Spa Adjuvanted antigenic meningococcal compositions
PL220107B1 (pl) * 2002-08-02 2015-08-31 Glaxosmithkline Biolog Sa Preparat immunogenny, szczepionka oraz zastosowanie tej szczepionki
BR0313120A (pt) * 2002-08-02 2007-07-17 Glaxosmithkline Biolog Sa preparações de bleb e de los, cepa(s) neisserial/neisseriais, composição imunogênica ou vacina, e, processos de fabricação da vacina de preparação de bleb neisserial e de produção de uma preparação de bleb
ES2608048T3 (es) 2002-10-11 2017-04-05 Glaxosmithkline Biologicals Sa Vacunas polipeptídicas para protección amplia contra linajes meningocócicos hipervirulentos
DK1556477T3 (en) 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying
ES2397923T3 (es) 2003-10-02 2013-03-12 Novartis Ag Vacunas líquidas para múltiples serogrupos meningocócicos
ES2346314T3 (es) 2003-10-02 2010-10-14 Glaxosmithkline Biolog Sa Antigenos de b. pertussis y uso de los mismos en vacunacion.
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
TW200800235A (en) 2005-10-18 2008-01-01 Otsuka Pharma Co Ltd Carrier composition for nucleic acid transport
JP5275982B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
US20090155873A1 (en) 2007-10-04 2009-06-18 Bio Architecture Lab, Inc. Biofuel production
BRPI0819813A2 (pt) * 2007-11-19 2015-05-26 Procter & Gamble Revestimento exterior para um artigo absorvente descartável
WO2009097346A2 (en) * 2008-01-28 2009-08-06 Bio Architecture Lab, Inc. Isolated alcohol dehydrogenase enzymes and uses thereof
CA2726465A1 (en) 2008-05-30 2009-12-30 Wendell David Zollinger Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
JP2013521326A (ja) 2010-03-10 2013-06-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
BR112012022800A2 (pt) 2010-03-11 2018-05-15 Glaxosmithkline Biologicals Sa composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
EP2613805B1 (en) 2010-09-10 2019-10-23 GlaxoSmithKline Biologicals SA Meningococcus overexpressing nada and/or nhba and outer membrane vesicles derived therefrom
ES2847923T3 (es) 2012-06-14 2021-08-04 Glaxosmithkline Biologicals Sa Vacunas contra el meningococo del serogrupo X
CZ2013450A3 (cs) * 2013-06-12 2014-02-12 Rieter Cz S.R.O. Způsob a zařízení ke sledování lineárního útvaru

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4550081A (en) 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
RU2023448C1 (ru) 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
US5785973A (en) 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
DE58901612D1 (de) 1988-03-24 1992-07-09 Zach Johann Druck- oder kraftmessvorrichtung.
AU8747791A (en) * 1990-08-23 1992-03-17 University Of North Carolina At Chapel Hill, The Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
FR2682041B1 (fr) 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
IL117483A (en) 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
US5646259A (en) 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
JP3974941B2 (ja) 1995-11-21 2007-09-12 イェール ユニバーシティ 単分子セグメントの増幅および検出
CU22559A1 (es) 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
PT1047784E (pt) * 1998-01-14 2009-12-21 Novartis Vaccines & Diagnostic Antigénios de neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
CA2314319C (en) 2013-08-13
CA2314319A1 (en) 1999-06-24
TR200001709T2 (tr) 2001-03-21
US6607729B2 (en) 2003-08-19
EP2354230A1 (en) 2011-08-10
US20090270591A1 (en) 2009-10-29
US8067004B2 (en) 2011-11-29
CN1284965A (zh) 2001-02-21
US6197312B1 (en) 2001-03-06
NO20002990L (no) 2000-08-08
JP2009045071A (ja) 2009-03-05
NO20002990D0 (no) 2000-06-09
US6495345B1 (en) 2002-12-17
KR20010033074A (ko) 2001-04-25
JP4651703B2 (ja) 2011-03-16
US20050058660A1 (en) 2005-03-17
US8034358B2 (en) 2011-10-11
US20130085262A1 (en) 2013-04-04
CN101684148A (zh) 2010-03-31
EP1045859A1 (en) 2000-10-25
EP1045859A4 (en) 2001-08-22
PL341160A1 (en) 2001-03-26
BR9814276A (pt) 2000-10-03
PL205984B1 (pl) 2010-06-30
US20120123093A1 (en) 2012-05-17
WO1999031132A1 (en) 1999-06-24
KR100571533B1 (ko) 2006-04-14
JP4356961B2 (ja) 2009-11-04
HUP0100094A1 (hu) 2001-05-28
AU1649599A (en) 1999-07-05
GB9726398D0 (en) 1998-02-11
CZ299646B6 (cs) 2008-10-01
IL199175A (en) 2013-07-31
US20020102276A1 (en) 2002-08-01
NZ505374A (en) 2002-03-01
JP2002508394A (ja) 2002-03-19
US20100331537A1 (en) 2010-12-30
AU747742B2 (en) 2002-05-23
IL136684A0 (en) 2001-06-14
CZ20002172A3 (cs) 2000-11-15

Similar Documents

Publication Publication Date Title
HUP0100094A3 (en) Novel surface antigen
DE69810130D1 (en) Rotationspumpe mit tauchrotor
PL339769A1 (en) Novel combination
ZA984107B (en) Resorcinyl-triazines
IL135343A0 (en) Novel aryloxy-alkyl-dialkylamines
DE19881579D2 (en) Kompressor mit überlastenkopplungseinrichtung
SI1036083T1 (en) Novel 9a-azalides
HUP9800744A3 (en) Antibodies against fas-antigene
SG66441A1 (en) Cleaner
GB9715597D0 (en) Surface modification process
GB9825184D0 (en) Antigen
GB9707372D0 (en) Cementitiuos tile
GB9726147D0 (en) Antigens
ZA985543B (en) Novel methods
GB9715836D0 (en) Surface fastener
GB2327585B (en) Surface construction
GB9710629D0 (en) Novel antigens
GB9701487D0 (en) Antigens
GB9800760D0 (en) Antigens
PL318601A1 (en) Novel 5-arylidene-4-oxo-2-imidazpglycines
AU2047P (en) Eskdale Poa labillardieri
EP1034276A4 (en) NEW ERA POLYPEPTIDES
CA81644S (en) Mug
GB9819015D0 (en) Antigens
GB9822143D0 (en) Antigens

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished